A Multiple-dose Study of LY3031207 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of LY2951742 in Participants With Migraine
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Japanese Participants With Moderate-to-Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol
- Status
- COMPLETED
- Phase
- PHASE1
Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2875358 in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2